Cargando…

Serial Analysis of 38 Proteins during the Progression of Human Breast Tumor in Mice Using an Antibody Colocalization Microarray

Proteins in serum or plasma hold great potential for use in disease diagnosis and monitoring. However, the correlation between tumor burden and protein biomarker concentration has not been established. Here, using an antibody colocalization microarray, the protein concentration in serum was measured...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huiyan, Bergeron, Sébastien, Annis, Matthew G., Siegel, Peter M., Juncker, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390249/
https://www.ncbi.nlm.nih.gov/pubmed/25680959
http://dx.doi.org/10.1074/mcp.M114.046516
_version_ 1782365664853360640
author Li, Huiyan
Bergeron, Sébastien
Annis, Matthew G.
Siegel, Peter M.
Juncker, David
author_facet Li, Huiyan
Bergeron, Sébastien
Annis, Matthew G.
Siegel, Peter M.
Juncker, David
author_sort Li, Huiyan
collection PubMed
description Proteins in serum or plasma hold great potential for use in disease diagnosis and monitoring. However, the correlation between tumor burden and protein biomarker concentration has not been established. Here, using an antibody colocalization microarray, the protein concentration in serum was measured and compared with the size of mammary xenograft tumors in 11 individual mice from the time of injection; seven blood samples were collected from each tumor-bearing mouse as well as control mice on a weekly basis. The profiles of 38 proteins detected in sera from these animals were analyzed by clustering, and we identified 10 proteins with the greatest relative increase in serum concentration that correlated with growth of the primary mammary tumor. To evaluate the diagnosis of cancer based on these proteins using either an absolute threshold (i.e. a concentration cutoff) or self-referenced differential threshold based on the increase in concentration before cell injection, receiver operating characteristic curves were produced for 10 proteins with increased concentration, and the area under curve was calculated for each time point based on a single protein or on a panel of proteins, in each case showing a rapid increase of the area under curve. Next, the sensitivity and specificity of individual and optimal protein panels were calculated, showing high accuracy as early as week 2. These results provide a foundation for studies of tumor growth through measuring serial changes of protein concentration in animal models.
format Online
Article
Text
id pubmed-4390249
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher The American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-43902492015-04-17 Serial Analysis of 38 Proteins during the Progression of Human Breast Tumor in Mice Using an Antibody Colocalization Microarray Li, Huiyan Bergeron, Sébastien Annis, Matthew G. Siegel, Peter M. Juncker, David Mol Cell Proteomics Research Proteins in serum or plasma hold great potential for use in disease diagnosis and monitoring. However, the correlation between tumor burden and protein biomarker concentration has not been established. Here, using an antibody colocalization microarray, the protein concentration in serum was measured and compared with the size of mammary xenograft tumors in 11 individual mice from the time of injection; seven blood samples were collected from each tumor-bearing mouse as well as control mice on a weekly basis. The profiles of 38 proteins detected in sera from these animals were analyzed by clustering, and we identified 10 proteins with the greatest relative increase in serum concentration that correlated with growth of the primary mammary tumor. To evaluate the diagnosis of cancer based on these proteins using either an absolute threshold (i.e. a concentration cutoff) or self-referenced differential threshold based on the increase in concentration before cell injection, receiver operating characteristic curves were produced for 10 proteins with increased concentration, and the area under curve was calculated for each time point based on a single protein or on a panel of proteins, in each case showing a rapid increase of the area under curve. Next, the sensitivity and specificity of individual and optimal protein panels were calculated, showing high accuracy as early as week 2. These results provide a foundation for studies of tumor growth through measuring serial changes of protein concentration in animal models. The American Society for Biochemistry and Molecular Biology 2015-04 2015-02-13 /pmc/articles/PMC4390249/ /pubmed/25680959 http://dx.doi.org/10.1074/mcp.M114.046516 Text en © 2015 by The American Society for Biochemistry and Molecular Biology, Inc. Author's Choice—Final version full access.
spellingShingle Research
Li, Huiyan
Bergeron, Sébastien
Annis, Matthew G.
Siegel, Peter M.
Juncker, David
Serial Analysis of 38 Proteins during the Progression of Human Breast Tumor in Mice Using an Antibody Colocalization Microarray
title Serial Analysis of 38 Proteins during the Progression of Human Breast Tumor in Mice Using an Antibody Colocalization Microarray
title_full Serial Analysis of 38 Proteins during the Progression of Human Breast Tumor in Mice Using an Antibody Colocalization Microarray
title_fullStr Serial Analysis of 38 Proteins during the Progression of Human Breast Tumor in Mice Using an Antibody Colocalization Microarray
title_full_unstemmed Serial Analysis of 38 Proteins during the Progression of Human Breast Tumor in Mice Using an Antibody Colocalization Microarray
title_short Serial Analysis of 38 Proteins during the Progression of Human Breast Tumor in Mice Using an Antibody Colocalization Microarray
title_sort serial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarray
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390249/
https://www.ncbi.nlm.nih.gov/pubmed/25680959
http://dx.doi.org/10.1074/mcp.M114.046516
work_keys_str_mv AT lihuiyan serialanalysisof38proteinsduringtheprogressionofhumanbreasttumorinmiceusinganantibodycolocalizationmicroarray
AT bergeronsebastien serialanalysisof38proteinsduringtheprogressionofhumanbreasttumorinmiceusinganantibodycolocalizationmicroarray
AT annismatthewg serialanalysisof38proteinsduringtheprogressionofhumanbreasttumorinmiceusinganantibodycolocalizationmicroarray
AT siegelpeterm serialanalysisof38proteinsduringtheprogressionofhumanbreasttumorinmiceusinganantibodycolocalizationmicroarray
AT junckerdavid serialanalysisof38proteinsduringtheprogressionofhumanbreasttumorinmiceusinganantibodycolocalizationmicroarray